TG Therapeutics Shares Gains on Briumvi Sales (TGTX:NASDAQ)


Business and customer review 2024 for strategic business planning in the coming year 2025

Joao Seraphim

Citing preliminary financials, TG Therapeutics (NASDAQ:TGTX) announced Tuesday that U.S. net sales of its multiple sclerosis therapy, Briumvi, for the fourth quarter and full year 2024 far exceeded its initial projections.

Following a presentation at the ongoing JP Morgan Healthcare Conference in San



Source link

  • Related Posts

    Oil prices jump nearly 5%, settle at highest since January 2025 amid Middle East conflict

    Oil prices jump nearly 5%, settle at highest since January 2025 amid Middle East conflict Source link

    Brookfield Asset Management launches $1 billion commercial paper program

    Brookfield Asset Management launches $1 billion commercial paper program Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *